← Sites
708 (USA)
USA
PI: Dr. Kim
activated
KRI 0.1
Patients
32
Active (enrolled/consented)
0
Withdrawn
3
Serious AEs
0
Open QA findings
1
Aged data queries
0
Studies & contracts total budget 349000.00 USD
Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II
study completed
contract executed
349000 USD
Patients first 32
| Ref | Status | Consented | Study |
|---|---|---|---|
| 708-1013 | screened | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. | |
| 708-1019 | completed | 2013-12-20 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 708-1032 | completed | 2013-02-09 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 708-1054 | screened | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. | |
| 708-1067 | screened | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. | |
| 708-1084 | completed | 2013-05-09 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 708-1087 | completed | 2012-10-22 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 708-1104 | screened | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. | |
| 708-1158 | completed | 2014-02-08 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 708-1171 | completed | 2012-12-06 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 708-1178 | withdrawn | 2013-12-29 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 708-1184 | screened | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. | |
| 708-1213 | completed | 2013-02-09 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 708-1216 | completed | 2012-10-24 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 708-1236 | withdrawn | 2013-09-21 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 708-1242 | screened | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. | |
| 708-1253 | completed | 2013-05-07 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 708-1272 | withdrawn | 2013-02-06 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 708-1286 | completed | 2013-09-10 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 708-1296 | completed | 2013-06-14 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 708-1297 | completed | 2013-01-25 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 708-1316 | completed | 2013-08-23 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 708-1336 | completed | 2012-12-07 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 708-1342 | completed | 2012-12-29 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 708-1347 | completed | 2013-04-20 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 708-1348 | completed | 2013-08-05 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 708-1352 | screened | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. | |
| 708-1353 | completed | 2013-07-04 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 708-1372 | completed | 2013-04-12 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 708-1378 | completed | 2013-09-03 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 708-1406 | completed | 2013-12-26 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 708-1428 | completed | 2013-11-09 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
Luna participants (0)
No participants at this site use Luna yet.
Safety 102 AEs · 0 serious
No serious adverse events at this site.
QA findings 1 open
open
major
Protocol deviation
PROTOCOL VIOLATION: PROTOCOL ENTRY CRITERIA NOT MET (subject 708-1372, 2013-05-10)
Monitoring visits (0)
No visits recorded.
Payments (0)
No payments on file.